<DOC>
	<DOC>NCT00855166</DOC>
	<brief_summary>This study is being carried out to see if dapagliflozin in addition to metformin decreases body weight and if so, how it compares with metformin alone.</brief_summary>
	<brief_title>Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Type 2 diabetes Ongoing treatment with metformin on a stable dose of ≥1500 mg/day for at least 12 weeks prior to enrolment Inadequate glycemic control, defined as HbA1c ≥6.5% and ≤8.5% ≥30 years for males ≥55 years for females Type 1 Diabetes Body weight change &gt;5% within 3 months prior to enrolment Renal and liver impairment</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Dapagliflozin</keyword>
	<keyword>Metformin</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>body weight</keyword>
</DOC>